Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-24-000769

Options or other derivatives

  • General Counsel acquired 109,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Nickson Philip General Counsel 2024-01-02 Grant or award · Stock Option (Right to Buy) +109,000 109,000 D
Loading xslF345X05/doc4.xml…